We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
-0.27%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$3.92B
AUM Growth
+$75.1M
Cap. Flow
+$135M
Cap. Flow %
3.46%
Top 10 Hldgs %
32.39%
Holding
6,700
New
1,026
Increased
2,252
Reduced
2,490
Closed
691

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$19.9M
2
SOXX icon
iShares Semiconductor ETF
SOXX
+$19M
3
EFA icon
iShares MSCI EAFE ETF
EFA
+$18.2M
4
CRM icon
Salesforce
CRM
+$16.1M
5
TSLA icon
Tesla
TSLA
+$14.7M

Sector Composition

Rank Sector Weight
1 Technology 18.67%
2 Consumer Discretionary 8.05%
3 Healthcare 7.35%
4 Communication Services 6.42%
5 Financials 6.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NTCO
3576
DELISTED
Natura &Co Holding S.A. American Depositary Shares (each representing two Common Shares)
NTCO
$24K ﹤0.01%
1,431
-1,191
-45% -$24.4K
ATCX
3577
DELISTED
Atlas Technical Consultants, Inc. Class A Common Stock
ATCX
$24K ﹤0.01%
2,338
-707
-23% -$7.31K
ATCO
3578
DELISTED
Atlas Corp.
ATCO
$24K ﹤0.01%
1,558
-1,827
-54% -$26.1K
BIOR
3579
DELISTED
Biora Therapeutics, Inc. Common Stock
BIOR
$24K ﹤0.01%
63
+13
+26% +$5.57K
PSTH
3580
DELISTED
Pershing Square Tontine Holdings, Ltd.
PSTH
$24K ﹤0.01%
1,223
-19,525
-94% -$396K
AIR icon
3581
AAR Corp
AIR
$5.77B
$23K ﹤0.01%
716
-12,782
-95% -$440K
AMTB icon
3582
Amerant Bancorp
AMTB
$1.15B
$23K ﹤0.01%
933
+146
+19% +$3.45K
ARQT icon
3583
Arcutis Biotherapeutics
ARQT
$3.3B
$23K ﹤0.01%
996
-1,860
-65% -$42.4K
ASIX icon
3584
AdvanSix
ASIX
$427M
$23K ﹤0.01%
568
-1,446
-72% -$49.7K
BCBP icon
3585
BCB Bancorp
BCBP
$161M
$23K ﹤0.01%
+1,581
New +$23.1K
BHE icon
3586
Benchmark Electronics
BHE
$2.94B
$23K ﹤0.01%
874
-1,874
-68% -$49.7K
CHPT icon
3587
ChargePoint
CHPT
$160M
$23K ﹤0.01%
57
-521
-90% -$243K
DEM icon
3588
WisdomTree Emerging Markets High Dividend Fund
DEM
$3.98B
$23K ﹤0.01%
524
-400
-43% -$17.9K
DLTH icon
3589
Duluth Holdings
DLTH
$151M
$23K ﹤0.01%
1,658
-1,468
-47% -$23.4K
DYN icon
3590
Dyne Therapeutics
DYN
$4.85B
$23K ﹤0.01%
1,458
-307
-17% -$5.44K
GSBC icon
3591
Great Southern Bancorp
GSBC
$877M
$23K ﹤0.01%
430
-4,943
-92% -$261K
GTBP icon
3592
GT Biopharma
GTBP
$10.7M
$23K ﹤0.01%
114
+105
+1,167% +$31.6K
GUNR icon
3593
FlexShares Global Upstream Natural Resources Index Fund
GUNR
$7B
$23K ﹤0.01%
627
+528
+533% +$19.7K
GUSH icon
3594
Direxion Daily S&P Oil & Gas Exp. & Prod. Bull 2X ETF
GUSH
$248M
$23K ﹤0.01%
1,020
-84,140
-99% -$1.54M
HBCP icon
3595
Home Bancorp
HBCP
$567M
$23K ﹤0.01%
577
JBSS icon
3596
John B. Sanfilippo & Son
JBSS
$989M
$23K ﹤0.01%
272
-354
-57% -$30.7K
KWEB icon
3597
KraneShares CSI China Internet ETF
KWEB
$5.31B
$23K ﹤0.01%
486
-5,714
-92% -$300K
LASR icon
3598
nLIGHT
LASR
$2.9B
$23K ﹤0.01%
808
-317
-28% -$9.43K
LIT icon
3599
Global X Lithium & Battery Tech ETF
LIT
$1.6B
$23K ﹤0.01%
280
+103
+58% +$8.44K
MNOV icon
3600
MediciNova
MNOV
$64.5M
$23K ﹤0.01%
6,051
-1,819
-23% -$6.91K

Similar funds

Tower Research Capital (TRC)'s Q3 2021 Portfolio in Review

As of Q3 2021, Tower Research Capital (TRC) held 6,700 positions worth $3.92B, up 2% from $3.84B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Tower Research Capital (TRC) deployed $135M of net new capital in Q3 2021, opening 1,026 new positions and adding to 2,252 existing holdings. Its largest new stake was Vanguard S&P 500 ETF: 107,857 shares worth $42.5M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 19% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was UnitedHealth, an estimated $19.9M trimmed.

  • Tower Research Capital (TRC)'s largest Q3 2021 buy was Vanguard S&P 500 ETF: 107,857 shares worth $42.5M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $342M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2021 reduction was UnitedHealth, cutting an estimated $19.9M.
  • Tower Research Capital (TRC) fully exited iShares Semiconductor ETF in Q3 2021, selling an estimated $19M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 32% of its $3.92B portfolio in Q3 2021.
  • Tower Research Capital (TRC) opened 1,026 new positions and closed 691 in Q3 2021.
  • Tower Research Capital (TRC)'s portfolio value rose 2% quarter-over-quarter to $3.92B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2021, filed 15 Nov 2021.